Tenet Healthcare (THC) stock
NYSE
As of the Nov 17, 2026 close (U.S. Eastern)
- Market cap
- $22.6B
- As of Nov 17, 2026
- P/E
- 7.78x
- Trailing twelve months
- P/B
- 4.15x
- Latest reported equity
- P/S
- 1.02x
- Trailing twelve months
- ROE
- 53.3%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
- Market cap
- $22.6B
- As of Nov 17, 2026
- P/E
- 7.78x
- Trailing twelve months
- P/B
- 4.15x
- Latest reported equity
- P/S
- 1.02x
- Trailing twelve months
- ROE
- 53.3%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
7.78x
P/B
4.15x
P/S
1.02x
Earnings and dividend metrics▾
Earnings
EPS
$36.24
Earnings per share
BPS
$68.05
Book value per share
ROE
53.3%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $36.24 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $68.05 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 53.3%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 6.5% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $5.29B+6.5%
$5.12B
Jul–Sep '24
$5.29B
Jul–Sep '25
$5.63B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 29, 2026.
- Earnings per share increased 221.5% from the same quarter a year earlier.
- Revenue increased 6.5% from the same quarter a year earlier.
- Operating income increased 96.9% from the same quarter a year earlier.
- Net income increased 192.4% from the same quarter a year earlier.
Filed Oct 29, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Blunt RoyDirector · Nov 11, 2026Open-market sale1,000 shares · $293KAvg. price $2933,589 shares held after
- KERREY J ROBERTDirector · Sep 14, 2026Open-market sale12,010 shares · $3.2MAvg. price $263.7244
Show 3 price lots
- 5,483 shares × $263.04$1.4M
- 4,025 shares × $264.1$1.1M
- 2,502 shares × $264.62$662K
- MARK RICHARD JDirector · Sep 10, 2026Open-market sale10,000 shares · $2.6MAvg. price $263.4225,121 shares held after
- West NadjaDirector · Sep 2, 2026Open-market sale1,152 shares · $298KAvg. price $258.823,653 shares held after
- Foo Lisa YEVP, Chief Operating Officer · Aug 31, 2026Open-market sale24,000 shares · $6.4MAvg. price $266.328,053 shares held after
- HANEY CECIL DDirector · Aug 28, 2026Gift150 shares · $0Avg. price $012,403 shares held after
- Sutaria SaumyaCEO · Aug 25, 2026Open-market sale50,000 shares · $13.7MAvg. price $274.0215
Show 3 price lots
- 24,881 shares × $274.1$6.8M
- 17,220 shares × $273.34$4.7M
- 7,899 shares × $275.26$2.2M
- Sutaria SaumyaCEO · Aug 24, 2026Open-market sale50,000 shares · $13.9MAvg. price $278.7052
Show 2 price lots
- 36,656 shares × $278.9$10.2M
- 13,344 shares × $278.17$3.7M
- HANEY CECIL DDirector · Aug 24, 2026Open-market sale1,300 shares · $361KAvg. price $278.0312,553 shares held after
- Romo TammyDirector · Aug 7, 2026Open-market sale2,500 shares · $652KAvg. price $260.8328,284 shares held after
- Romo TammyDirector · Aug 6, 2026Open-market sale4,922 shares · $1.3MAvg. price $264.1530,784 shares held after
- Blunt RoyDirector · Aug 5, 2026Open-market sale600 shares · $158KAvg. price $262.684,589 shares held after
- Foo Lisa YEVP, Chief Operating Officer · Jul 29, 2026Open-market sale10,000 shares · $2.6MAvg. price $258.0332,053 shares held after
- Arbour Paola MEVP, Chief Information Officer · Jul 27, 2026Open-market sale10,878 shares · $2.7MAvg. price $243.918,413 shares held after
- BIERMAN JAMES LDirector · Jul 27, 2026Open-market sale5,000 shares · $1.2MAvg. price $244.9631,604 shares held after
- Lynch Christopher S.Director · Jul 27, 2026Open-market sale3,837 shares · $934KAvg. price $243.449,568 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Tenet Healthcare (THC) stock information
NYSE
Tenet Healthcare (THC) is listed on NYSE. Its market capitalization is about $22.6B. On trailing-twelve-month earnings the P/E ratio is 7.78, and the P/B ratio is 4.15. Return on equity is 53.3%. These figures are computed in-house from official filings and are reference information only.
Tenet Healthcare — frequently asked questions
- What is the P/E ratio of Tenet Healthcare (THC)?
- On a trailing-twelve-month basis, THC trades at a P/E ratio of 7.78. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Tenet Healthcare?
- THC has a market capitalization of about $22.6B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.